
NextPlat Corp. (NASDAQ:NXPL – Free Report) – Investment analysts at Litchfield Hills Research boosted their Q2 2027 EPS estimates for shares of NextPlat in a research note issued on Thursday, July 16th. Litchfield Hills Research analyst T. O’neill now forecasts that the company will earn $0.15 per share for the quarter, up from their prior forecast of $0.14. Litchfield Hills Research has a “Buy” rating and a $11.00 price objective on the stock. The consensus estimate for NextPlat’s current full-year earnings is ($0.55) per share. Litchfield Hills Research also issued estimates for NextPlat’s Q4 2027 earnings at $0.18 EPS and FY2027 earnings at $0.58 EPS.
A number of other research analysts have also recently issued reports on the stock. Weiss Ratings upgraded shares of NextPlat from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Monday, May 11th. Zacks Research upgraded NextPlat to a “hold” rating in a research note on Thursday, June 25th. One investment analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $11.00.
NextPlat Trading Down 8.3%
Shares of NXPL opened at $6.06 on Friday. NextPlat has a 1 year low of $3.38 and a 1 year high of $11.10. The company has a current ratio of 2.56, a quick ratio of 2.12 and a debt-to-equity ratio of 0.05. The stock has a 50 day simple moving average of $6.53 and a 200-day simple moving average of $5.98. The stock has a market cap of $16.42 million, a PE ratio of -1.40 and a beta of 1.87.
NextPlat (NASDAQ:NXPL – Get Free Report) last announced its quarterly earnings data on Thursday, May 14th. The company reported ($0.42) EPS for the quarter. NextPlat had a negative net margin of 23.14% and a negative return on equity of 58.05%. The company had revenue of $9.86 million for the quarter.
Institutional Investors Weigh In On NextPlat
An institutional investor recently bought a new stake in NextPlat stock. Citadel Advisors LLC bought a new stake in NextPlat Corp. (NASDAQ:NXPL – Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned 0.19% of NextPlat at the end of the most recent quarter. 1.30% of the stock is currently owned by institutional investors.
NextPlat Company Profile
NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.
Further Reading
- Five stocks we like better than NextPlat
- Palantir’s Wild Ride: Inside the Stock Wall Street Can’t Agree On
- Has Broadcom Become Too Expensive for Its AI Story?
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
Receive News & Ratings for NextPlat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextPlat and related companies with MarketBeat.com's FREE daily email newsletter.
